Guru Ownership Trend
Guru Analysis for Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $126.58 M.
Top institutional holders include Andreas Halvorsen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $1.92 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 337.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 4.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Inhibrx Biosciences, Inc. (INBX)
Major holders include Andreas Halvorsen ($96.66 M), Renaissance Technologies (RenTech) ($3.37 M), Jefferies Group ($2.62 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.54 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.92 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited INBX. The total reported sell value was $162,494.91.
Yes, 0 managers opened new positions in INBX, and 2 increased their existing holdings. The total reported buy value was $2.08 M.